Medical device developers and manufacturers like Stryker (NYSE:SYK) are changing how they approach design as digital technology becomes more crucial. Four Stryker executives shared how the Kalamazoo, Michigan–based orthopedic device giant is thinking differently about medical product development and how health care providers and patients will ultimately use them. The DeviceTalks Boston panel of Stryker […]
Implants
Medtronic completes Intersect ENT acquisition
Medtronic (NYSE:MDT) announced that it completed its previously announced $1.1 billion acquisition of Intersect ENT (Nasdaq:XENT). Fridley, Minnesota-based Medtronic announced in August 2021 that it would acquire all outstanding shares of the Menlo Park, California-based sinus implant maker for $28.25 per share in an all-cash transaction. As a result of the transaction, Medtronic acquires Intersect […]
FDA approves magnetic resonance labeling for CVRx’s Barostim neuromodulation system
CVRx (Nasdaq:CVRX) announced today that the FDA approved magnetic resonance (MR) conditional labeling for its Barostim system. The Barostim neuromodulation system for treating the symptoms of heart failure now includes instructions to allow for safe MRI scans of the head and lower extremities, offering heart failure patients implanted with Barostim more diagnostic options. Minneapolis-based CVRx […]
Axonics raises 2022 sales guidance on Street-beating Q1
Axonics Modulation Technologies (Nasdaq:AXNX) reported first-quarter financial results that topped analysts’ consensus forecast. The Irvine, California–based sacral neuromodulation technology developer posted losses of $22.7 million, or 50¢ per share, on sales of $48.4 million for the three months ended March 31, 2022, for a slight bottom-line loss of just over $150,000 year-over-year on sales growth […]
Orthofix beats The Street in Q1, reaffirms 2022 guidance
Orthofix (Nasdaq:OFIX) recorded first-quarter financial results that came in ahead of the consensus forecast on Wall Street. The Lewisville, Texas-based orthopedic implant company posted losses of $4.5 million, or 22¢ per share, on sales of $106.4 million for the three months ended March 31, 2022, for a slight bottom-line gain closer to breakeven on sales […]
The cloud is transforming medtech: Amazon, Microsoft, Google, J&J, Philips and GE Healthcare leaders explain
Leaders in medtech and cloud computing discuss payoffs and potential in device connectivity, product development and cross-industry partnerships. If knowledge is power, that power comes from a steady stream of information, and we know there’s no shortage of that in healthcare. The challenge has long been how to capture that information, store it, analyze it […]
NuVasive beats The Street in Q1, raises 2022 guidance
NuVasive (Nasdaq:NUVA) shares ticked up today on first-quarter results that came in ahead of the consensus forecast. The San Diego–based spine surgery tech company posted profits of $19.2 million, or 35¢ per share, on sales of $290.8 million for the three months ended March 31, 2022, for a massive bottom-line gain out of the red […]
Staar Surgical rises on Street-beating Q1, Evo lens shipments remain ‘robust’
Staar Surgical (Nasdaq:STAA) shares got a boost this morning on first-quarter results that topped the consensus forecast. STAA shares were up 11% at $70.91 per share as the market opened today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down 0.4%. However, Staar shares were down […]
Orthofix wins FDA PMA for bone growth stimulation device
Orthofix (Nasdaq:OFIX) announced today that it received FDA premarket approval (PMA) for its AccelStim bone healing therapy device. Lewisville, Texas-based Orthofix designed the AccelStim device to provide a safe and effective nonsurgical treatment for indicated fresh fractures and for fractures that have not healed (nonunions). According to a news release, the device generates a low-intensity […]
SeaSpine rises on Q1 earnings, increased 2022 revenue outlook
SeaSpine (Nasdaq:SPNE) shares rose today on first-quarter results that were mixed compared to the consensus forecast. The Carlsbad, California–based spine treatment tech company posted losses of $16.6 million, or 45¢ per share, on sales of $50.7 million for the three months ended March 31, 2022, for a 30% bottom-line slide further into the red on […]
Zimmer Biomet rises on Street-beating Q1, raised guidance
Zimmer Biomet (NYSE:ZBH) shares ticked up today on first-quarter results ahead of the consensus forecast, with ZB upping its 2022 forecast. The Warsaw, Indiana–based company posted profits of $14.2 million, or 7¢ per share, on sales of $1.7 billion for the three months ended March 31, 2022, for a 92.8% bottom-line slide on sales growth […]